Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Urologic Oncology|April 23, 2019
Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladderAshish Tyagi, Balaji Chandrasekaran, Venkatesh Kolluru, et al.Cureus|November 30, 2022
Information Seeking Practices and Availability of Smart Devices Among Healthcare Professionals in a Lower-Middle-Income Country: An Analysis From PakistanSufyan Razak, Shilpa Bai, Faiza Zakaria, et al.Toxicology and Applied Pharmacology|October 20, 2023
Exposure of environmental trace elements in prostate cancer patients: A multiple metal analysisBhawna Tyagi, Balaji Chandrasekaran, Ashish Tyagi, et al.Oncogenesis|February 19, 2020
Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cellsBalaji Chandrasekaran, Nisha R Dahiya, Ashish Tyagi, et al.Carcinogenesis|August 21, 2018
The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis modelsBalaji Chandrasekaran, Deeksha Pal, Venkatesh Kolluru, et al.Journal of Hazardous Materials|July 9, 2026
Integrated analyses of the microbiome, metabolome, and spatial transcriptomics reveal sex-dependent bladder vulnerability to chronic inorganic arsenicBhawna Tyagi, Ashish Tyagi, Mohit Vashishta, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2020
Diagnostic molecular markers predicting aggressive potential in low-grade prostate cancerUttara Saran, Balaji Chandrasekaran, Venkatesh Kolluru, et al.Urologic Oncology|September 10, 2018
miR-301a expression: Diagnostic and prognostic marker for prostate cancerVenkatesh Kolluru, Balaji Chandrasekaran, Ashish Tyagi, et al.Molecular Cancer Therapeutics|October 22, 2020
ASR490, a Small Molecule, Overrides Aberrant Expression of <i>Notch1</i> in Colorectal CancerAshish Tyagi, Balaji Chandrasekaran, Venkatesh Kolluru, et al.Frontiers in Pharmacology|March 20, 2023
Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7Balaji Chandrasekaran, Ashish Tyagi, Uttara Saran, et al.Pageof 5